Cargando…
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
A deeper understanding of COVID‐19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)‐based proteomics to measure serum proteomes of COVID‐19 patients and symptomatic, but PCR‐negat...
Autores principales: | Geyer, Philipp E, Arend, Florian M, Doll, Sophia, Louiset, Marie‐Luise, Virreira Winter, Sebastian, Müller‐Reif, Johannes B, Torun, Furkan M, Weigand, Michael, Eichhorn, Peter, Bruegel, Mathias, Strauss, Maximilian T, Holdt, Lesca M, Mann, Matthias, Teupser, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687121/ https://www.ncbi.nlm.nih.gov/pubmed/34232570 http://dx.doi.org/10.15252/emmm.202114167 |
Ejemplares similares
-
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
por: Buchholtz, Marie-Luise, et al.
Publicado: (2021) -
Transparent Exploration
of Machine Learning for Biomarker
Discovery from Proteomics and Omics Data
por: Torun, Furkan M., et al.
Publicado: (2022) -
Revisiting biomarker discovery by plasma proteomics
por: Geyer, Philipp E, et al.
Publicado: (2017) -
Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
por: Geyer, Philipp E, et al.
Publicado: (2019) -
From genotype to phenotype in human atherosclerosis - recent findings
por: Holdt, Lesca M., et al.
Publicado: (2013)